Glenn Greenberg recent buys & sells (2015 Q2)
Brave Warrior Advisors
Brave Warrior Advisors Portfolio Changes
Purchase & sale details
- Portfolio value:
- $3.46B (+$187M)
- Previous value:
- $3.28B
- # of changes:
- 14
- New positions:
- 2
- Reported for:
- 30 Jun 2015 (Q2)
- Latest filing date:
- 14 Aug 2015
Brave Warrior Advisors has disclosed a total of 14 changes to the portfolio in the (2015 Q2) SEC report(s): increased the number of shares of 4, bought 2 totally new, decreased the number of shares of 7 and completely sold out 1 position(s).
What stocks did Glenn Greenberg buy in 2015 Q2?
During 2015 Q2 Glenn Greenberg has bought 6 securities out of which top 5 purchases (by % change to portfolio) were (JPM) JPMorgan Chase & Co (added shares +1.17%), (HAL) Halliburton Company (added shares +3.27%), (BN) Brookfield Corp (new buy), (PRI) Primerica Inc (added shares +27.81%) and (JPMWS) JPMORGAN CHASE & CO-CW18 (added shares +43.91%).
What did Glenn Greenberg invest in during 2015 Q2?
In the 2015 Q2 report(s) the following changes have been made to the top investments: (VRX) Valeant Pharmaceuticals International Inc (reduced shares -2.99%), (JPM) JPMorgan Chase & Co (added shares +1.17%), (SCHW) Charles Schwab Corp (reduced shares -4.70%), (MSFT) Microsoft Corp (reduced shares -0.03%) and (HAL) Halliburton Company (added shares +3.27%).
14 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Antero Resources Corp
|
new
|
$34.34
|
+13.79%($39.08)
|
1.88%
|
2015 Q2
|
~0.25 years
|
||||
|
|
Brookfield Corp
|
new
|
$23.29
|
+56.03%($36.34)
|
5.49%
|
2015 Q2
|
~0.25 years
|
||||
|
|
JPMORGAN CHASE & CO-CW18
|
+43.91%
|
$24.75
|
|
2.76%
|
2015 Q1
|
~0.50 years
|
||||
|
|
Primerica Inc
|
+27.81%
|
$45.69
|
+514.83%($280.92)
|
3.56%
|
2013 Q2*
|
> 2 years
|
||||
|
|
Halliburton Company
|
+3.27%
|
$43.07
|
-24.26%($32.62)
|
7.15%
|
2014 Q4
|
~0.75 years
|
||||
|
|
JPMorgan Chase & Co
|
+1.17%
|
$67.76
|
+395.90%($336.02)
|
9.54%
|
2014 Q3
|
~1.00 year
|
||||
|
|
Microsoft Corp
|
-0.03%
|
$44.15
|
+1,109.27%($533.90)
|
7.94%
|
2013 Q3
|
~2.00 years
|
||||
|
|
Equinix Inc
|
-0.45%
|
$246.36
|
+295.06%($973.27)
|
6.44%
|
2014 Q2
|
~1.25 years
|
||||
|
|
Valeant Pharmaceuticals International Inc
|
-2.99%
|
$222.15
|
|
36.57%
|
2013 Q2*
|
> 2 years
|
||||
|
|
Charles Schwab Corp
|
-4.70%
|
$32.65
|
+175.85%($90.06)
|
8.26%
|
2013 Q2*
|
> 2 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".